Table 1.
Clinical characteristics of our population.
| NG Patients | HG Patients | |
|---|---|---|
| N | 106 | 103 |
| Mean age (years) | 75.0 ± 6.5 | 76.0 ± 6.1 |
| BMI (kg/m2) | 27.1 ± 1.9 | 27.3 ± 1.8 |
| SBP (mmHg) | 128.9 ± 12.4 | 129.2 ± 11.8 |
| DBP (mmHg) | 78.8 ± 6.6 | 79.2 ± 6.3 |
| Heart rate (bpm) | 87.5 ± 8.3 | 88.2 ± 8.2 |
| Comorbidities | ||
| Diabetes, n (%) | 56 (52.0) | 103 (100) |
| Dyslipidemia, n (%) | 66 (63.0) | 66 (64.0) |
| CVD, n (%) | 29 (30.0) | 31 (30.5) |
| COPD, n (%) | 38 (36.5) | 39 (38.0) |
| CKD n (%) | 43 (41.0) | 44 (43.0) |
| Current smokers, n (%) | 44 (41.5) | 41 (40.0) |
| Active treatments | ||
| β-blockers, n (%) | 61 (58.0) | 57 (56.0) |
| ACE inhibitors, n (%) | 73 (69.0) | 70 (68.0) |
| Angiotensin receptor blockers, n (%) | 35 (33.0) | 33 (32.0) |
| Calcium inhibitors, n (%) | 24 (23.0) | 28 (27.0) |
| Statins, n (%) | 57 (54.0) | 54 (53.0) |
| Diuretics, n (%) | 8 (8.0) | 11 (11.0) |
| Aspirin, n (%) | 46 (44.0) | 50 (49.0) |
| Laboratory analyses | ||
| Plasma glucose (mg/dL) | 124.6 ± 11.8 | 207.3 ± 18.6 |
| Total cholesterol (mg/dL) | 193.9 ± 19.8 | 192.6 ± 20.2 |
| Creatinine (mg/dL) | 1.0 ± 0.1 | 1.0 ± 0.1 |
ACE: angiotensin converting enzyme; BMI: body mass index; COPD: chronic obstructive pulmonary disease; CKD: chronic kidney disease; CVD: cardiovascular disease; DBP: diastolic blood pressure; HG: hyperglycemic; NG: normoglycemic; SBP: systolic blood pressure.